Enhanced Group Inc.
For the period ended May 6, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 6, 2026 · Filed May 8, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Development of the Live Enhanced Platform
Development of the Live Enhanced Platform
Performance of the Live Enhanced business will depend on the Company’s ability to convert public interest in the Enhanced Games into paying subscribers and recurring services revenue. Key variables include:
Customer acquisition efficiency. The cost of acquiring new subscribers through paid and organic marketing will directly affect unit economics.
Subscriber retention and engagement. Continued use of the Live Enhanced platform’s physician-guided programs, supplements, and data tools will determine lifetime value per customer.
Product breadth and clinical integration. Expanding our initial offering of testosterone replacement therapy to additional hormone, metabolic, cognitive, and longevity protocols, as well as supplements and other products, will increase addressable market size.
Partnership performance. The platform’s scalability depends on the reliability and compliance performance of partners for clinical delivery.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.